Literature DB >> 28049633

Progressive epigenetic dysregulation in neuroendocrine tumour liver metastases.

Anna Karpathakis1,2, Harpreet Dibra1, Christodoulos Pipinikas1, Andrew Feber1, Tiffany Morris1, Joshua Francis3, Dahmane Oukrif1, Dalvinder Mandair1,2, Marinos Pericleous2, Mullan Mohmaduvesh2, Stefano Serra4, Olagunju Ogunbiyi3, Marco Novelli1, TuVinh Luong2, Sylvia L Asa4, Matthew Kulke5, Christos Toumpanakis2, Tim Meyer1,2, Martyn Caplin2, Stephan Beck1, Christina Thirlwell6,2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28049633     DOI： 10.1530/ERC-16-0419

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN： 1351-0088            Impact factor:   5.678


× No keyword cloud information.
  11 in total

Review 1.  Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies.

Authors:  Gitta Boons; Timon Vandamme; Marc Peeters; Guy Van Camp; Ken Op de Beeck
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

Review 2.  Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms.

Authors:  Georgios Kyriakopoulos; Vasiliki Mavroeidi; Eleftherios Chatzellis; Gregory A Kaltsas; Krystallenia I Alexandraki
Journal:  Ann Transl Med       Date:  2018-06

3.  Telomerase activation in small intestinal neuroendocrine tumours is associated with aberrant TERT promoter methylation, but not hot-spot mutations.

Authors:  Omid Fotouhi; Mehran Ghaderi; Na Wang; Jan Zedenius; Magnus Kjellman; Dawei Xu; C Christofer Juhlin; Catharina Larsson
Journal:  Epigenetics       Date:  2019-07-19       Impact factor: 4.528

Review 4.  Systemic Therapy of Advanced Well-differentiated Small Bowel Neuroendocrine Tumors Progressive on Somatostatin Analogues.

Authors:  Parul Agarwal; Amr Mohamed
Journal:  Curr Treat Options Oncol       Date:  2022-08-08

Review 5.  Management of neuroendocrine tumors of unknown primary.

Authors:  Krystallenia Alexandraki; Anna Angelousi; Georgios Boutzios; Georgios Kyriakopoulos; Dimitra Rontogianni; Gregory Kaltsas
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 6.  Neuroendocrine Neoplasms of the Small Bowel and Pancreas.

Authors:  Ashley Kieran Clift; Mark Kidd; Lisa Bodei; Christos Toumpanakis; Richard P Baum; Kjell Oberg; Irvin M Modlin; Andrea Frilling
Journal:  Neuroendocrinology       Date:  2019-09-27       Impact factor: 5.135

7.  Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors.

Authors:  Dirk Walter; Patrick N Harter; Florian Battke; Ria Winkelmann; Markus Schneider; Katharina Holzer; Christine Koch; Jörg Bojunga; Stefan Zeuzem; Martin Leo Hansmann; Jan Peveling-Oberhag; Oliver Waidmann
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

Review 8.  Immune checkpoint therapy in liver cancer.

Authors:  Feng Xu; Tianqiang Jin; Yuwen Zhu; Chaoliu Dai
Journal:  J Exp Clin Cancer Res       Date:  2018-05-29

9.  Molecular prognostic factors in small-intestinal neuroendocrine tumours.

Authors:  K G Samsom; L M van Veenendaal; G D Valk; M R Vriens; M E T Tesselaar; J G van den Berg
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

Review 10.  Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead.

Authors:  Annamaria Colao; Filomena de Nigris; Roberta Modica; Claudio Napoli
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-15       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.